Cargando…

Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis

Preclinical and human studies suggest that hippocampal dysfunction is a key factor in the onset of psychosis. People at Clinical High Risk for psychosis (CHR-P) present with a clinical syndrome that can include social withdrawal and have a 20–35% risk of developing psychosis in the next 2 years. Rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davies, Cathy, Paloyelis, Yannis, Rutigliano, Grazia, Cappucciati, Marco, De Micheli, Andrea, Ramella-Cravaro, Valentina, Provenzani, Umberto, Antoniades, Mathilde, Modinos, Gemma, Oliver, Dominic, Stahl, Daniel, Murguia, Silvia, Zelaya, Fernando, Allen, Paul, Shergill, Sukhi, Morrison, Paul, Williams, Steve, Taylor, David, McGuire, Philip, Fusar-Poli, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784972/ https://www.ncbi.nlm.nih.gov/pubmed/30626906 http://dx.doi.org/10.1038/s41386-018-0311-6

Ejemplares similares

S149. EFFECTS OF INTRANASAL OXYTOCIN ON RESTING CEREBRAL BLOOD FLOW IN PEOPLE AT ULTRA-HIGH RISK FOR PSYCHOSIS
por: Davies, Cathy, et al.
Publicado: (2018)

T139. OXYTOCIN ENHANCES NEURAL EFFICIENCY IN INFERRING OTHERS’ SOCIAL EMOTIONS IN PEOPLE AT CLINICAL HIGH RISK FOR PSYCHOSIS
por: Schmidt, André, et al.
Publicado: (2020)

Acute oxytocin effects in inferring others’ beliefs and social emotions in people at clinical high risk for psychosis
por: Schmidt, André, et al.
Publicado: (2020)

Diagnostic and Prognostic Significance of Brief Limited Intermittent Psychotic Symptoms (BLIPS) in Individuals at Ultra High Risk
por: Fusar-Poli, Paolo, et al.
Publicado: (2017)

Intranasal oxytocin increases heart-rate variability in men at clinical high risk for psychosis: a proof-of-concept study
por: Martins, Daniel, et al.
Publicado: (2020)

Mapping the implementation and challenges of clinical services for psychosis prevention in England
por: Estradé, Andrés, et al.
Publicado: (2023)

Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis
por: Fusar-Poli, Paolo, et al.
Publicado: (2016)

Transdiagnostic Individualized Clinically Based Risk Calculator for the Detection of Individuals at Risk and the Prediction of Psychosis: Model Refinement Including Nonlinear Effects of Age
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

34.2 IMPROVING THE DETECTION OF INDIVIDUALS AT RISK OF PSYCHOSIS IN SECONDARY MENTAL HEALTH CARE
por: Fusar-poli, Paolo, et al.
Publicado: (2018)

Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis
por: Davies, Cathy, et al.
Publicado: (2018)

Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling study
por: Oliver, Dominic, et al.
Publicado: (2023)

Formal thought disorder in people at ultra-high risk of psychosis
por: Demjaha, Arsime, et al.
Publicado: (2017)

Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk and the Prediction of Psychosis: Second Replication in an Independent National Health Service Trust
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation
por: Schmidt, André, et al.
Publicado: (2017)

Effects of Benzodiazepine Exposure on Real-World Clinical Outcomes in Individuals at Clinical High-Risk for Psychosis
por: Livingston, Nicholas R., et al.
Publicado: (2023)

Physical Health in Clinical High Risk for Psychosis Individuals: A Cross-Sectional Study
por: Provenzani, Umberto, et al.
Publicado: (2023)

T122. UNMET NEEDS IN PATIENTS WITH ACUTE TRANSIENT PSYCHOTIC DISORDERS (ATPD): ANALYSIS OF PATHWAYS TO CARE: AN 8 YEARS FOLLOW-UP STUDY
por: Minichino, Amedeo, et al.
Publicado: (2018)

Salivary and plasmatic oxytocin are not reliable trait markers of the physiology of the oxytocin system in humans
por: Martins, Daniel, et al.
Publicado: (2020)

Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes
por: Modinos, Gemma, et al.
Publicado: (2021)

F256. CAN WE REDUCE THE DURATION OF UNTREATED PSYCHOSIS?
por: Oliver, Dominic, et al.
Publicado: (2018)

Investigating resting brain perfusion abnormalities and disease target-engagement by intranasal oxytocin in women with bulimia nervosa and binge-eating disorder and healthy controls
por: Martins, Daniel, et al.
Publicado: (2020)

M163. GLUTAMATE METABOLITES ARE ASSOCIATED WITH ALTERED HIPPOCAMPAL ACTIVATION BUT NOT HIPPOCAMPAL-STRIATAL CONNECTIVITY IN SUBJECTS WITH A CLINICAL HIGH RISK FOR PSYCHOSIS
por: Hird, Emily, et al.
Publicado: (2020)

Towards a Standard Psychometric Diagnostic Interview for Subjects at Ultra High Risk of Psychosis: CAARMS versus SIPS
por: Fusar-Poli, P., et al.
Publicado: (2016)

Neighbourhood deprivation is positively associated with detection of the ultra-high risk (UHR) state for psychosis in South East London
por: Bhavsar, V., et al.
Publicado: (2018)

Pan-London Network for Psychosis-Prevention (PNP)
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis
por: Schmidt, A., et al.
Publicado: (2017)

Outreach and support in South-London (OASIS) 2001—2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis
por: Fusar-Poli, Paolo, et al.
Publicado: (2020)

Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care
por: Fusar-Poli, Paolo, et al.
Publicado: (2020)

The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis
por: Fusar-Poli, Paolo, et al.
Publicado: (2016)

Can We Reduce the Duration of Untreated Psychosis? A Systematic Review and Meta-Analysis of Controlled Interventional Studies
por: Oliver, Dominic, et al.
Publicado: (2018)

Clinical-learning versus machine-learning for transdiagnostic prediction of psychosis onset in individuals at-risk
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

Oxytocin modulates local topography of human functional connectome in healthy men at rest
por: Martins, Daniel, et al.
Publicado: (2021)

S150. EMOTIONAL BEHAVIOUR IN HIGH-RISK AND FIRST-EPISODE PSYCHOSIS
por: Falkenberg, Irina, et al.
Publicado: (2020)

Corrigendum to “Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care” [EClinicalMedicine 28 (2020) 100,578]
por: Fusar-Poli, Paolo, et al.
Publicado: (2021)

Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function
por: Allen, Paul, et al.
Publicado: (2021)

M136. PSYCHOSIS POLYRISK SCORE (PPS): IMPROVING DETECTION OF INDIVIDUALS AT-RISK AND PREDICTION OF CLINICAL OUTCOMES
por: Oliver, Dominic, et al.
Publicado: (2020)

E-Clinical High Risk for Psychosis: Viewpoint on Potential of Digital Innovations for Preventive Psychiatry
por: Reilly, Thomas, et al.
Publicado: (2019)

Correction: Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function
por: Allen, Paul, et al.
Publicado: (2021)

What Causes the Onset of Psychosis in Individuals at Clinical High Risk? A Meta-analysis of Risk and Protective Factors
por: Oliver, Dominic, et al.
Publicado: (2020)

Comorbid Depressive and Anxiety Disorders in 509 Individuals With an At-Risk Mental State: Impact on Psychopathology and Transition to Psychosis
por: Fusar-Poli, Paolo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_900l2c1ujs53s72ve8k37lv43v